Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00491400 · ClinicalTrials.gov registry record · NA

Effect of a Fibrate and a Statin on Endothelial Dysfunction

A NA study, sponsored by Boston University.

Terminated
Registry status
NA
Development phase
28
Enrollment target

NCT00491400: Clinical Trial NA study, sponsored by Boston University.

NCT00491400 is a NA study that was terminated before completion, run by Boston University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00491400, a NA study, was terminated before completion, sponsored by Boston University.

TERMINATED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The study will compare the effect of atorvastatin to the effect of fenofibrate on endothelial function in patients with diabetes mellitus or the metabolic syndrome.

Primary Outcome

Endothelial function was assessed as brachial artery flow-mediated dilation (FMD) using ultrasound. FMD is calculated as the difference in brachial diameter during hyperemic flow and brachial diameter at baseline divided by brachial diameter at baseline and expressed as percent dilation.

Interventions

  • DRUG Fenofibrate
  • DRUG Atorvastatin

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2005-09
Est. Completion 2008-12
Phase NA
Boston University

185 total trials

Why NCT00491400 stopped before completion

NCT00491400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Fenofibrate is the first listed.

NCT00491400 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00491400 about?

NCT00491400 is a clinical study titled "Effect of a Fibrate and a Statin on Endothelial Dysfunction". The study will compare the effect of atorvastatin to the effect of fenofibrate on endothelial function in patients with diabetes mellitus or the metabolic syndrome.

What is the current status of trial NCT00491400?

This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2005-09. Estimated completion is 2008-12.

What interventions are being tested in trial NCT00491400?

The interventions under investigation include: Fenofibrate (DRUG), Atorvastatin (DRUG).

Who is sponsoring clinical trial NCT00491400?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00491400's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00491400, the US trial registry maintained by the National Library of Medicine. NCT00491400 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.